Androgen replacement therapy male patients rheumatoid arthritis hypogonadic condition low serum testosterone levels male patients rheumatoid arthritis RA men active RA months oral testosterone undecanoate nonsteroidal antiinflammatory drug attempt immunologic response overall clinical response sex hormone response replacement therapy end months significant increase serum testosterone levels increase number cells decrease cell ratio IgM rheumatoid factor concentration concurrent significant reduction number affected joints daily intake nonsteroidal antiinflammatory drugs well-known immunosuppressive action androgens findings RA patients 